Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis

NCT04333147 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT04333147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
May 12, 2020
Completion date
February 24, 2023
Enrollment
2,916 (actual)
Sites
375

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid